"Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter]." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, , pp. 557–558
View responses to this article:
Disclosure
The authors report no conflicts of interest in this communication.